For patients undergoing treatment with cancer immunotherapy, immune-related adverse events most often present on the skin and can be so severe that patients opt to discontinue treatment. On this episode of CANCER BUZZ, we look at dermatology’s role in the cancer care continuum and how cancer teams can better integrate dermatology into the immunotherapy care process. Guest:

• Joshua Arbesman, MD, Dermatologist, Cleveland Clinic

Related Content:

• ACCC Immuno-Oncology Institute
• Supportive Oncodermatology
• Managing IO Toxicities: Three Keys to Success, by Sigrun Hallmeyer, MD
• Immunotherapy & Mental Health (podcast)
• The Immunotherapy Patient Perspective (podcast)

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.